Source: European Journal of Pharmacology. Unidades: FCFRP, FMRP
Subjects: HIPERTENSÃO, ISQUEMIA MIOCÁRDICA, METABOLISMO DE PROTEÍNA
ABNT
MELLO, Marcela Maria Blascke de et al. Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension. European Journal of Pharmacology, v. 983, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2024.176981. Acesso em: 26 abr. 2026.APA
Mello, M. M. B. de, Neves, V. G. de O., Parente, J. M., Pernomian, L., Oliveira, I. S. de, Pedersoli, C. A., et al. (2024). Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension. European Journal of Pharmacology, 983. doi:10.1016/j.ejphar.2024.176981NLM
Mello MMB de, Neves VG de O, Parente JM, Pernomian L, Oliveira IS de, Pedersoli CA, Awata WMC, Tirapelli CR, Arantes EC, Tostes R de CA, Schulz R, Castro MM de. Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension [Internet]. European Journal of Pharmacology. 2024 ; 983[citado 2026 abr. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176981Vancouver
Mello MMB de, Neves VG de O, Parente JM, Pernomian L, Oliveira IS de, Pedersoli CA, Awata WMC, Tirapelli CR, Arantes EC, Tostes R de CA, Schulz R, Castro MM de. Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension [Internet]. European Journal of Pharmacology. 2024 ; 983[citado 2026 abr. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176981
